|
WO2011066479A1
|
|
Lacrimal implants including split and insertable drug core
|
|
BRPI1008030A2
|
|
tear implants and related methods
|
|
US2010040670A1
|
|
Drug delivery via ocular implant
|
|
WO2010006053A1
|
|
Lacrimal implant body including comforting agent
|
|
CA2728623A1
|
|
Combination treatment of glaucoma
|
|
BRPI0912182A2
|
|
prolonged release distribution of active agents to treat glaucoma and ocular hypertension
|
|
CN102112076A
|
|
Lacrimal implants and related methods
|
|
CN102119075A
|
|
Surface treated implantable articles and related methods
|
|
WO2009035565A1
|
|
Prostaglandin analogues for implant devices and methods
|
|
CN101861135A
|
|
Lacrimal implant detection
|
|
CN101969897A
|
|
Insertion and extraction tools for lacrimal implants
|
|
CN101505683A
|
|
Drug delivery methods, structures, and compositions for nasolacrimal system
|
